First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
2018 · Journal of Translational Medicine · 528 citations
https://doi.org/10.1186/s12967-018-1507-6
J
Jian Campian
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
270
Papers
7.3K
Citations
40
h-index
76
i10-index
Jian Campian is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Brain Metastases and Treatment & Cancer Immunotherapy and Biomarkers. The author has an h-index of 40, co-authored 230 publications.
ORCID: 0000-0002-5317-8481Papers by this author
worksCorrection to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
2018 · Journal of Translational Medicine · 17 citations
https://doi.org/10.1186/s12967-018-1552-1
Cytotoxic and mutagenic effects of tobacco-borne free fatty acids
2005 · Free Radical Biology and Medicine · 7 citations
https://doi.org/10.1016/j.freeradbiomed.2005.09.033
Bevacizumab exerts dose-dependent risk for intracranial hemorrhage in patients with malignant gliomas
2025 · Journal of Neuro-Oncology · 3 citations
https://doi.org/10.1007/s11060-024-04916-8
CSF-Derived cfDNA Methylation Profiling to Distinguish True Progression from Radiation Necrosis and Pseudoprogression in GBM Patients
2025 · International Journal of Radiation Oncology*Biology*Physics · 0 citations
https://doi.org/10.1016/j.ijrobp.2025.06.2118
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat